"positive breast cancer" trang 5 - tải miễn phí từ tailieunhanh
Response to neoadjuvant chemotherapy based on pathologic complete response in very young patients with ER-positive breast cancer: A large, multicenter, observational study

Response to neoadjuvant chemotherapy based on pathologic complete response in very young patients with ER-positive breast cancer: A large, multicenter, observational study
11    49    1
Prognostic significance of the skeletal muscle index and systemic inflammatory index in patients with lymph node-positive breast cancer after radical mastectomy

Prognostic significance of the skeletal muscle index and systemic inflammatory index in patients with lymph node-positive breast cancer after radical mastectomy
9    20    1
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients

Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
10    18    1
Genetic and RNA-related molecular markers of trastuzumab-chemotherapy-associated cardiotoxicity in HER2 positive breast cancer: A systematic review

Genetic and RNA-related molecular markers of trastuzumab-chemotherapy-associated cardiotoxicity in HER2 positive breast cancer: A systematic review
14    19    1
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
10    5    1
Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer

Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer
20    4    1
Multi-vendor evaluation of artificial intelligence as an independent reader for double reading in breast cancer screening on 275,900 mammograms

Multi-vendor evaluation of artificial intelligence as an independent reader for double reading in breast cancer screening on 275,900 mammograms
13    5    1
Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: A single-institution study with 10-year follow-up

Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: A single-institution study with 10-year follow-up
9    10    1
Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: Final results of the exploratory phase 2 Victor-5 study

Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: Final results of the exploratory phase 2 Victor-5 study
10    1    1
PIK3CA mutation status, progression and survival in advanced HR+/HER2- breast cancer: A meta-analysis of published clinical trials

PIK3CA mutation status, progression and survival in advanced HR+/HER2- breast cancer: A meta-analysis of published clinical trials
11    1    1
Factors associated with initiation and continuation of endocrine therapy in women with hormone receptor-positive breast cancer

Factors associated with initiation and continuation of endocrine therapy in women with hormone receptor-positive breast cancer
12    16    1
High score of LDH plus dNLR predicts poor survival in patients with HER2- positive advanced breast cancer treated with trastuzumab emtansine

High score of LDH plus dNLR predicts poor survival in patients with HER2- positive advanced breast cancer treated with trastuzumab emtansine
13    36    3
GDNF-RET signaling and EGR1 form a positive feedback loop that promotes tamoxifen resistance via cyclin D1

GDNF-RET signaling and EGR1 form a positive feedback loop that promotes tamoxifen resistance via cyclin D1
14    1    1
Serum soluble ST2 is associated with ER-positive breast cancer

Serum soluble ST2 is associated with ER-positive breast cancer
8    28    1
Reproductive factors and risk of hormone receptor positive and negative breast cancer: A cohort study

Reproductive factors and risk of hormone receptor positive and negative breast cancer: A cohort study
12    64    1
Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2- negative breast cancer: A randomized pilot trial

Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2- negative breast cancer: A randomized pilot trial
12    43    1
The MTT viability assay yields strikingly false-positive viabilities although the cells are killed by some plant extracts

The MTT viability assay yields strikingly false-positive viabilities although the cells are killed by some plant extracts
7    116    0
Analytical validation of CanAssist-Breast: An immunohistochemistry based prognostic test for hormone receptor positive breast cancer patients

Analytical validation of CanAssist-Breast: An immunohistochemistry based prognostic test for hormone receptor positive breast cancer patients
10    43    1
MET and PTEN gene copy numbers and Ki-67 protein expression associate with pathologic complete response in ERBB2- positive breast carcinoma patients treated with neoadjuvant trastuzumab-based therapy

MET and PTEN gene copy numbers and Ki-67 protein expression associate with pathologic complete response in ERBB2- positive breast carcinoma patients treated with neoadjuvant trastuzumab-based therapy
11    55    1
Effectiveness of the AJCC 8th edition staging system for selecting patients with T1–2N1 breast cancer for post-mastectomy radiotherapy: A joint analysis of 1986 patients from two institutions

Effectiveness of the AJCC 8th edition staging system for selecting patients with T1–2N1 breast cancer for post-mastectomy radiotherapy: A joint analysis of 1986 patients from two institutions
11    48    1